Collegium Pharmaceutical Inc (STU:354)
€ 19.8 +0.40 (+2.06%) Market Cap: 646.55 Mil Enterprise Value: 1.49 Bil PE Ratio: 18.50 PB Ratio: 2.39 GF Score: 69/100

Collegium Pharmaceutical, Inc. at Morgan Stanley Global Healthcare Conference Transcript

Sep 15, 2026 / 08:05 PM GMT
Release Date Price: €18.7 (-5.08%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

COLL.OQ - Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. at Morgan Stanley Global Healthcare Conference
Sep 15, 2026 / 08:05PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great. Good afternoon. My name is Bob Klingenberger. I'm the Executive Director at Morgan Stanley. I'm really pleased to be joined by the Collegium team here this afternoon, Vikram Karnani, CEO, and Colleen Tupper, CFO. And just before we get started, for any research disclaimers, please just visit Morgan Stanley.

And if any questions, please reach out to your Morgan Stanley representative.

And like I said, thrilled to be joined here by the Collegium team. And I think Vikram and Colleen, just maybe to kind of kick things off, historically, I think the company has been viewed as really a pain management company. I think fair to say that the story today is increasingly
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot